Literature DB >> 26424792

Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.

Amy E Moritz1, Danielle E Rastedt1, Daniel J Stanislowski1, Madhur Shetty1, Margaret A Smith1, Roxanne A Vaughan2, James D Foster3.   

Abstract

The dopamine transporter is a neuronal protein that drives the presynaptic reuptake of dopamine (DA) and is the major determinant of transmitter availability in the brain. Dopamine transporter function is regulated by protein kinase C (PKC) and other signaling pathways through mechanisms that are complex and poorly understood. Here we investigate the role of Ser-7 phosphorylation and Cys-580 palmitoylation in mediating steady-state transport kinetics and PKC-stimulated transport down-regulation. Using both mutational and pharmacological approaches, we demonstrate that these post-translational modifications are reciprocally regulated, leading to transporter populations that display high phosphorylation-low palmitoylation or low phosphorylation-high palmitoylation. The balance between the modifications dictates transport capacity, as conditions that promote high phosphorylation or low palmitoylation reduce transport Vmax and enhance PKC-stimulated down-regulation, whereas conditions that promote low phosphorylation or high palmitoylation increase transport Vmax and suppress PKC-stimulated down-regulation. Transitions between these functional states occur when endocytosis is blocked or undetectable, indicating that the modifications kinetically regulate the velocity of surface transporters. These findings reveal a novel mechanism for control of DA reuptake that may represent a point of dysregulation in DA imbalance disorders.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DHHC; acyl protein transferases; post-translational modification (PTM); protein acylation; protein kinase C (PKC); protein palmitoylation; protein phosphorylation

Mesh:

Substances:

Year:  2015        PMID: 26424792      PMCID: PMC4661421          DOI: 10.1074/jbc.M115.667055

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.

Authors:  C Saunders; J V Ferrer; L Shi; J Chen; G Merrill; M E Lamb; L M Leeb-Lundberg; L Carvelli; J A Javitch; A Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  Palmitoylation and depalmitoylation defects.

Authors:  Thorsten Hornemann
Journal:  J Inherit Metab Dis       Date:  2014-08-05       Impact factor: 4.982

3.  The brain in flux: genetic, physiologic, and therapeutic perspectives on transporters in the CNS.

Authors:  Randy D Blakely; Arturo Ortega; Michael B Robinson
Journal:  Neurochem Int       Date:  2014-04-18       Impact factor: 3.921

4.  Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.

Authors:  G M Daniels; S G Amara
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

5.  Flotillins regulate membrane mobility of the dopamine transporter but are not required for its protein kinase C dependent endocytosis.

Authors:  Tatiana Sorkina; John Caltagarone; Alexander Sorkin
Journal:  Traffic       Date:  2013-03-11       Impact factor: 6.215

6.  Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.

Authors:  Yvette Dehnes; Jufang Shan; Thijs Beuming; Lei Shi; Harel Weinstein; Jonathan A Javitch
Journal:  Neurochem Int       Date:  2014-02-24       Impact factor: 3.921

Review 7.  Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders.

Authors:  Raajaram Gowrishankar; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-11-11       Impact factor: 3.921

Review 8.  SLC6 transporters: structure, function, regulation, disease association and therapeutics.

Authors:  Akula Bala Pramod; James Foster; Lucia Carvelli; L Keith Henry
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

9.  Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Authors:  Freja H Hansen; Tina Skjørringe; Saiqa Yasmeen; Natascha V Arends; Michelle A Sahai; Kevin Erreger; Thorvald F Andreassen; Marion Holy; Peter J Hamilton; Viruna Neergheen; Merete Karlsborg; Amy H Newman; Simon Pope; Simon J R Heales; Lars Friberg; Ian Law; Lars H Pinborg; Harald H Sitte; Claus Loland; Lei Shi; Harel Weinstein; Aurelio Galli; Lena E Hjermind; Lisbeth B Møller; Ulrik Gether
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

10.  Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux.

Authors:  James D Foster; Jae-Won Yang; Amy E Moritz; Sathyavathi Challasivakanaka; Margaret A Smith; Marion Holy; Kyle Wilebski; Harald H Sitte; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

View more
  25 in total

1.  Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Authors:  Danielle E Bolland; Amy E Moritz; Daniel J Stanislowski; Roxanne A Vaughan; James D Foster
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

2.  Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.

Authors:  Cody A Siciliano; Kaustuv Saha; Erin S Calipari; Steve C Fordahl; Rong Chen; Habibeh Khoshbouei; Sara R Jones
Journal:  J Neurosci       Date:  2017-11-24       Impact factor: 6.167

3.  Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity.

Authors:  Jae-Won Yang; Garret Larson; Lisa Konrad; Madhur Shetty; Marion Holy; Kathrin Jäntsch; Mirja Kastein; Seok Heo; Fatma Asli Erdem; Gert Lubec; Roxanne A Vaughan; Harald H Sitte; James D Foster
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

4.  Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.

Authors:  Hong Jiang; Xiaoyu Zhang; Xiao Chen; Pornpun Aramsangtienchai; Zhen Tong; Hening Lin
Journal:  Chem Rev       Date:  2018-01-02       Impact factor: 60.622

Review 5.  Direct dopamine terminal regulation by local striatal microcircuitry.

Authors:  Suzanne O Nolan; Jennifer E Zachry; Amy R Johnson; Lillian J Brady; Cody A Siciliano; Erin S Calipari
Journal:  J Neurochem       Date:  2020-06-19       Impact factor: 5.372

6.  Phosphomimetic substitution at Ser-33 of the chloroquine resistance transporter PfCRT reconstitutes drug responses in Plasmodium falciparum.

Authors:  Cecilia P Sanchez; Sonia Moliner Cubel; Britta Nyboer; Monika Jankowska-Döllken; Christine Schaeffer-Reiss; Daniel Ayoub; Gabrielle Planelles; Michael Lanzer
Journal:  J Biol Chem       Date:  2019-07-08       Impact factor: 5.157

Review 7.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

8.  Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.

Authors:  Sathya Challasivakanaka; Juan Zhen; Margaret E Smith; Maarten E A Reith; James D Foster; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2017-09-22       Impact factor: 5.157

Review 9.  Model systems for analysis of dopamine transporter function and regulation.

Authors:  Moriah J Hovde; Garret H Larson; Roxanne A Vaughan; James D Foster
Journal:  Neurochem Int       Date:  2018-09-01       Impact factor: 3.921

10.  Regulation of TRPP3 Channel Function by N-terminal Domain Palmitoylation and Phosphorylation.

Authors:  Wang Zheng; JungWoo Yang; Erwan Beauchamp; Ruiqi Cai; Shaimaa Hussein; Laura Hofmann; Qiang Li; Veit Flockerzi; Luc G Berthiaume; Jingfeng Tang; Xing-Zhen Chen
Journal:  J Biol Chem       Date:  2016-10-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.